Evidence map›Paper›PMID 26300992›Full record

ReviewClinical epigenetics2015

The placenta: phenotypic and epigenetic modifications induced by Assisted Reproductive Technologies throughout pregnancy.

Cécile Choux, Virginie Carmignac, Céline Bruno, Paul Sagot, Daniel Vaiman, Patricia Fauque

Open access · goldAbstract readReview
In one paragraph

Review in Clinical epigenetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
16.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Stability of epigenetic transgenerational inheritance of adult-onset disease and parturition abnormalities.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Cécile ChouxHôpital de Dijon, Université de Bourgogne, Service de Gynécologie-Obstétrique, Médecine Fœtale et Stérilité Conjugale, 21079 Dijon, France ; Equipe GAD, Génétique des Anomalies du Développement, EA 4271, Université de Bourgogne, Dijon, France.
Virginie CarmignacEquipe GAD, Génétique des Anomalies du Développement, EA 4271, Université de Bourgogne, Dijon, France.
Céline BrunoEquipe GAD, Génétique des Anomalies du Développement, EA 4271, Université de Bourgogne, Dijon, France ; Hôpital de Dijon, Université de Bourgogne, Laboratoire de Biologie de la Reproduction, 21079 Dijon, France.
Paul SagotHôpital de Dijon, Université de Bourgogne, Service de Gynécologie-Obstétrique, Médecine Fœtale et Stérilité Conjugale, 21079 Dijon, France.
Daniel VaimanInstitut Cochin, Team Epigénétique et Physiopathologie de la Reproduction, U1016 Inserm/UMR8104 CNRS/UMR-S8104, 24, rue du Faubourg St Jacques, 75014 Paris, France.
Patricia FauqueEquipe GAD, Génétique des Anomalies du Développement, EA 4271, Université de Bourgogne, Dijon, France ; Hôpital de Dijon, Université de Bourgogne, Laboratoire de Biologie de la Reproduction, 21079 Dijon, France.
Université de Bourgogne · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Today, there is growing interest in the potential epigenetic risk related to assisted reproductive technologies (ART). Much evidence in the literature supports the hypothesis that adverse pregnancy outcomes linked to ART are associated with abnormal trophoblastic invasion. The aim of this review is to investigate the relationship between epigenetic dysregulation caused by ART and subsequent placental response. The dialogue between the endometrium and the embryo is a crucial step to achieve successful trophoblastic invasion, thus ensuring a non-complicated pregnancy and healthy offspring. However, as described in this review, ART could impair both actors involved in this dialogue. First, ART may induce epigenetic defects in the conceptus by modifying the embryo environment. Second, as a result of hormone treatments, ART may impair endometrial receptivity. In some cases, it results in embryonic growth arrest but, when the development of the embryo continues, the placenta could bring adaptive responses throughout pregnancy. Amongst the different mechanisms, epigenetics, especially thanks to a finely tuned network of imprinted genes stimulated by foetal signals, may modify nutrient transfer, placental growth and vascularization. If these coping mechanisms are overwhelmed, improper maternal-foetal exchanges occur, potentially leading to adverse pregnancy outcomes such as abortion, preeclampsia or intra-uterine growth restriction. But in most cases, successful placental adaptation enables normal progress of the pregnancy. Nevertheless, the risks induced by these modifications during pregnancy are not fully understood. Metabolic diseases later in life could be exacerbated through the memory of epigenetic adaptation mechanisms established during pregnancy. Thus, more research is still needed to better understand abnormal interactions between the embryo and the milieu in artificial conditions. As trophectoderm cells are in direct contact with the environment, they deserve to be studied in more detail. The ultimate goal of these studies will be to render ART protocols safer. Optimization of the environment will be the key to improving the dialogue between the endometrium and embryo, so as to ensure that placentation after ART is similar to that following natural conception.

Indexed as

Assisted Reproductive TechnologiesEpigeneticImprinted genePlacentaPregnancy

Identifiers

PMID26300992
PMCPMC4546204
OpenAlexW2115944887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.